Contemporary nuclear medicine imaging of neuroendocrine tumours

This publication has 100 references indexed in Scilit:

• The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
  Pancreas, 2010
• New imaging approaches to phaeochromocytomas and paragangliomas
  Clinical Endocrinology, 2010
• Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
  The Journal of Clinical Endocrinology & Metabolism, 2009
• ¹⁸F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
  Journal of Nuclear Medicine, 2009
• Comparison of 6-¹⁸F-Fluorodopamine PET with ¹²³I-Metaiodobenzylguanidine and ¹¹¹In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma
  Journal of Nuclear Medicine, 2008
• A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors
  Nuclear Medicine and Biology, 2008
• The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study
  European Journal of Surgical Oncology, 2008
• Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
  The Journal of Clinical Endocrinology & Metabolism, 2007
• [11C]Metahydroxyephedrine and [18F]Fluorodeoxyglucose Positron Emission Tomography Improve Clinical Decision Making in Suspected Pheochromocytoma
  Annals of Surgical Oncology, 2006
• Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer
  Annals of Surgical Oncology, 2004